Company intelligence / Profile preview

PictorLabs

Los Angeles, California, United Statespictorlabs.ai ↗

Ownership: Private
Employees: ~30
Development stage: Other

Overview

PictorLabs has developed an AI-driven virtual staining platform that transforms label-free tissue images into stain-equivalent visuals in minutes. The technology eliminates the need for chemical reagents and enables rapid, non-destructive histopathology workflows. It has demonstrated analytical concordance with traditional stains and reduces tissue consumption by over 50%. The product is currently available for research use only and not approved for clinical diagnostics. No clinical trial results are applicable as this is a digital pathology tool.

Industry: Pathology

Partnerships

PathPresenter (integration of virtual stain technology into enterprise image management platforms)Collaborations with biopharma companies and CROs

Beyond the preview

Go deeper on PictorLabs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PictorLabs.

Explore the full profile